NCT00552370View on ClinicalTrials.gov

Glycemic Optimization Treatment Study

PHASE4CompletedINTERVENTIONAL
Enrollment

5,062

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Lantus®

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00552370 - Glycemic Optimization Treatment Study | Biotech Hunter | Biotech Hunter